Consistently, in mouse models of NASH, the liver showed downregulation of HNF4α and HNF1α and up-regulation of PPARγ and SREBP-1c, as compared to controls (Figure 6D). The gene discussed is HNF4A; the disease is metabolic dysfunction-associated steatohepatitis.